AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 296: R952-R959, 2009. First published January 28, 2009; doi:10.1152/ajpregu.90537.2008
0363-6119/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/4/R952    most recent
90537.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sachidanandam, K.
Right arrow Articles by Ergul, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sachidanandam, K.
Right arrow Articles by Ergul, A.

RECEPTORS AND SIGNALING PATHWAYS

Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1

Kamakshi Sachidanandam,1 Jim R. Hutchinson,2 Mostafa M. Elgebaly,1 Erin M. Mezzetti,2 Anne M. Dorrance,3 Kouros Motamed,4 and Adviye Ergul1,2

1Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4Abraxis BioScience, Marina del Rey, California

Submitted 26 June 2008 ; accepted in final form 23 January 2009

Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of Type 1 diabetes in vascular remodeling, we recently extended these observations to Type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ETA receptors, whereas blockade of ETB receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for Type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ETA receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ETA receptors alter vascular structure and mechanics in Type 2 diabetes.

vascular remodeling; vascular compliance; glycemic control; extracellular matrix; endothelin receptors



Address for reprint requests and other correspondence: A. Ergul, Medical College of Georgia, 1120 15th St., CA 2094, Augusta, GA 30912 (e-mail: aergul{at}mcg.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.